EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds’ Metabolic and Anti-Tumor Effects

Lucia Camelia Pirvu iD, Amalia Stefaniu iD, Sultana Nita, Nicoleta Radu iD, Georgeta Neagu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lucia Camelia Pirvu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biotechnologies, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 03129…. Hauptthemen laut MEDLINE: Fragaria, Plant Extracts, Antineoplastic Agents, Phytogenic, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Nucleu" Program, UEFISCDI, Grant no. 1N/2023, Project code PN23-28 BioChemLife", Nucleu” Program, UEFISCDI, MCID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plant extracts contain many small molecules that are less investigated. The present paper aims to study in silico physical-chemical, pharmacokinetic, medicinal chemistry and lead/drug-likeness properties and the ability to interfere with the activity of P-glycoprotein (P-gp) transporter and cytochrome P450 (CYP) oxidase system in humans of phloridzin, phloretin, 4-methylchalcone metabolic series alongside the top three compounds found in the ethanolic extract from strawberries (S), namely 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one, 2-pyrrolidinone 5-(cyclohexylmethyl) and hexadecanoic acid. The phloridzin derivatives also were studied for their inhibitory potential upon Bcl-2, TNKS1 and COX-2 molecular targets. In vitro, Caco-2 studies analyzed the cytoprotective and anti-proliferative activity of S and the three phloridzin derivatives (pure compounds) in comparison with their combination 1:1 (GAE/pure compound, w/w), in the range 1 to 50 µg active compounds per test sample. Altogether, it was concluded that phloretin (Phl) can be used alone or in combination with S to support intestinal cell health in humans. Phloridzin (Phd) and phloridzin combined with S were proven ineffective. 4-methylchalcone (4-MeCh) combined with S indicated no advantages, while the pure compound exhibited augmented inhibitory effects, becoming a candidate for combinations with anticancer drugs. Overall, in silico studies revealed possible limitations in the practical use of phloridzin derivatives due to their potential to interfere with the activity of several major CYP enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FragariaPlant ExtractsAntineoplastic Agents, PhytogenicAntineoplastic AgentsHumansCaco-2 CellsComputer SimulationCell ProliferationPhlorhizinPhloretinMolecular Docking SimulationChalcones

Stichwörter der Autor:innen

2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one 2-pyrrolidinone 5-(cyclohexyl…40% ethanolic extract from strawberry fruitsCaco-2in silico CLC docking analysis for Bcl-2 TNKS and COX-2 targetsin silico SwissADME analysisin vitro cytotoxicity and anti-proliferative studiesphloridzin phloretin and 4-methylchalcone

Substanzen

Plant ExtractsPhlorhizinAntineoplastic Agents, PhytogenicAntineoplastic AgentsPhloretinChalcones

Autor:innen und Institutionen

  • Department of Pharmaceutical Biotechnologies, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.
  • Department of Physical-Chemical Analysis and Quality Control, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.
  • Biotechnology Faculty, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti, District 1, 011464 Bucharest, Romania.
  • Department of Biotechnology, National Institute of Chemistry and Petrochemistry Research and Development, 202 Splaiul Independentei, 060021 Bucharest, Romania.
  • Department of Pharmacology, National Institute for Chemical Pharmaceutical Research and Development (INCDCF-ICCF), 112 Vitan, 031299 Bucharest, Romania.

ORCID-Profile: Lucia Camelia Pirvu, Amalia Stefaniu, Nicoleta Radu, Georgeta Neagu

Förderung

  • "Nucleu" Program, UEFISCDI, Grant no. 1N/2023, Project code PN23-28 BioChemLife"
  • Nucleu” Program, UEFISCDI
  • MCID

Zitieren

APA

Pirvu, L. C., Stefaniu, A., Nita, S., Radu, N., & Neagu, G. (2025). In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds’ Metabolic and Anti-Tumor Effects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083492

Vancouver

Pirvu LC, Stefaniu A, Nita S, Radu N, Neagu G. In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds’ Metabolic and Anti-Tumor Effects. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083492

BibTeX
@article{Pirvu2025,
  author = {Pirvu, Lucia Camelia and Stefaniu, Amalia and Nita, Sultana and Radu, Nicoleta and Neagu, Georgeta},
  title = {In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds’ Metabolic and Anti-Tumor Effects},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083492}
}
Kostenlos starten →